Clinical Trial Update: BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease [Phase 4]

View source ↗

Summary

A Phase 4 naturalistic trial of IPX-203 for Parkinson disease is currently recruiting in the BOOST-PD study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• IPX-203

Snippet

Sponsor: The Cleveland Clinic | Conditions: Parkinson Disease | Phase 4 | Status: RECRUITING